GBM cell lines, including U87, U251 and serum-free cultured U87 (to mimic the stem cell culture condition) cells, were exposed to increasing concentrations of an HDAC inhibitor (panobinostat or vorinostat) or the bromodomain inhibitor JQ1 for 72 h. This evidence concerns the gene HDAC9 and glioblastoma.